Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ ultraviolet light (PUVA) in human epithelial cells
- 1 January 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (1), 125-132
- https://doi.org/10.1016/0006-2952(91)90020-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Overexpression of Transforming Growth Factor α in Psoriatic EpidermisScience, 1989
- Altered [125I] Epidermal Growth Factor Binding and Receptor Distribution in PsoriasisJournal of Investigative Dermatology, 1986
- Altered degradation of epidermal growth factor in a diphtheria toxin-resistant clone of KB cellsJournal of Cellular Physiology, 1985
- Intracellular Ca2+ and phorbol esters synergistically inhibit internalization of epidermal growth factor in pancreatic aciniBiochemical Journal, 1984
- Regulation of Cell Proliferation by Epidermal Growth FactorCritical Reviews in Biochemistry, 1983
- 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasisBritish Journal of Dermatology, 1979
- Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptorsNature, 1979
- Risk of Cutaneous Carcinoma in Patients Treated with Oral Methoxsalen Photochemotherapy for PsoriasisNew England Journal of Medicine, 1979
- Oral Methoxsalen Photochemotherapy for The Treatment of Psoriasis: a Cooperative Clinical TrialJournal of Investigative Dermatology, 1977
- 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.The Journal of cell biology, 1976